In the present, replacement therapy of C1-inhibitor is also another established treatment for hereditary angioedema in addition to anti-C5 antibodies for C-dependent hemolytic anemia in patients with paroxysmal nocturnal hemoglobinuria, respectively [155,156]. The gene discussed is C5; the disease is paroxysmal nocturnal hemoglobinuria.